Interventional medical systems

Information

  • Patent Grant
  • 10463853
  • Patent Number
    10,463,853
  • Date Filed
    Thursday, January 19, 2017
    7 years ago
  • Date Issued
    Tuesday, November 5, 2019
    5 years ago
Abstract
An implantable medical device includes ventricular and atrial portions, and a flexible leadlet that extends therebetween. An open channel of the atrial portion, formed along a core thereof, is sized to receive the leadlet therein, when the leadlet is folded over on itself. An interventional medical system includes the device and a delivery tool; a tubular sidewall of the tool defines a lumen and has a tether extending therein. A slot formed in the sidewall extends proximally from an open end thereof, coincident with a distal opening of the lumen. When the atrial portion is contained within the lumen, a segment of the leadlet extends alongside the atrial portion; another segment of the leadlet, being folded over on itself, proximal to the atrial portion, has the tether engaged therewith. The slot may allow passage of the leadlet therethrough, when the atrial portion is positioned for deployment through the distal opening.
Description
FIELD OF THE DISCLOSURE

The present disclosure pertains to interventional medical systems, and, more particularly, to relatively compact implantable medical devices and delivery tools thereof.


BACKGROUND

The traditional implantable cardiac pacemaker includes a pulse generator device to which one or more flexible elongate lead wires are coupled. The device is typically implanted in a subcutaneous pocket, remote from the heart, and each of the one or more lead wires extends therefrom to a corresponding electrode, coupled thereto and positioned at a pacing site, either endocardial or epicardial. Mechanical complications and/or MRI compatibility issues, which are sometimes associated with elongate lead wires and well known to those skilled in the art, have motivated the development of implantable cardiac pacing devices that are wholly contained within a relatively compact package, the entirety of which is configured for implant in close proximity to a pacing site. Such a relatively compact intra-cardiac device configured for dual chamber pacing may be implanted as shown in the schematic diagram of FIG. 1. FIG. 1 illustrates a dual chamber intra-cardiac pacing device including a first portion 10 implanted in a right ventricle RV of a heart, in proximity to an apex thereof, and a second portion 20 implanted in a right atrium RA of the heart, within an appendage 102 thereof. FIG. 1 further illustrates the device including a leadlet 12 that connects first portion 10 to second portion 20. There is a need for improved interventional medical systems facilitating the implant of relatively compact intra-cardiac dual chamber pacing devices like that illustrated in FIG. 1.


BRIEF SUMMARY

According to embodiments disclosed herein, an implantable medical device includes a ventricular portion, which has an electrode and a fixation mechanism, both mounted in proximity to a distal end of a hermetically sealed housing of the ventricular portion, an atrial portion, which has a core extending from a first end thereof to a second end thereof, along a longitudinal axis of the atrial portion, and a flexible leadlet that extends from a proximal end of the ventricular portion housing to the first end of the atrial portion core, the leadlet being coupled to an atrial electrode mounted in proximity to the second end of the core; wherein the atrial portion includes an open channel formed along the core thereof, the open channel extending between the first and second ends of the core and being sized to receive the leadlet therein, when the leadlet is folded over on itself.


According to some embodiments, a plurality of elastically deformable tines form a fixation mechanism of the atrial portion and are fixedly mounted to the core, being spaced apart from one another around a perimeter of the core. Each tine preferably includes: a proximal, spring portion being fixedly attached to the atrial portion core and having a spring-biased pre-formed curvature, the pre-formed curvature, in proximity to the core, extending in a first direction, generally parallel to the axis of the atrial portion, and then sweeping laterally, outward from the axis; and a distal portion including a proximal section, a hook section, and tip section terminated by a rounded free distal end, the proximal section extending from the proximal, spring portion and being pre-formed to extend in a second direction and along a relatively straight line to the hook section, the proximal section being oriented, by the spring-biased pre-formed curvature of the proximal, spring portion, so that the second direction is generally opposite the first direction, and the relatively straight line intersects the axis at an acute angle of between about 30 degrees and about 50 degrees, the hook section having a deformable pre-formed curvature that extends from the proximal section back toward the axis of the atrial portion, the tip section being pre-formed to extend along a relatively straight line from the hook section to the rounded free distal end, and the tip section being oriented, by the pre-formed curvature of the hook section, when un-deformed, to extend toward the axis of the atrial portion, such that the tip section and the proximal section enclose an angle in a range from about 90 degrees to about 120 degrees; and wherein, when the atrial portion of the device is loaded within a tubular sidewall of a delivery tool, so that the rounded free distal end of each tine engages an inner surface of the sidewall, to hold the proximal, spring portion of each tine in a spring-loaded condition, each tip section of the distal portion extends away from the axis of the atrial portion at an acute angle in a range from about 45 degrees to about 75 degrees for deployment of the corresponding rounded free distal end out from the tool tubular sidewall; and upon deployment of the rounded free distal end of each tine, the tip section of each distal portion rotates away from the axis to approach an angle of 90 degrees, relative to the axis, in response to an initial release of the spring-loaded condition of the corresponding proximal, spring portion.


The device may be included in an interventional medical system along with a delivery tool that includes a tubular sidewall and a tether extending therein, the tubular sidewall defining a lumen and having a slot formed therein, wherein the slot extends proximally from an open end thereof, which is coincident with a distal opening of the lumen. The device is loaded in the delivery tool such that the second end of the atrial portion core faces the proximal end of the ventricular portion housing, such that the atrial portion thereof is contained within the lumen with a segment of the leadlet extending alongside the atrial portion, and with another segment of the flexible leadlet being folded over on itself proximal to the atrial portion, and such that the tether is engaged with the other segment of the leadlet at a fold therein. The slot of the tool is configured to allow passage of the flexible leadlet therethrough when the atrial portion is positioned in proximity to the distal opening of the lumen for deployment from the tool.





BRIEF DESCRIPTION OF THE DRAWINGS

The following drawings are illustrative of particular embodiments of the present invention and therefore do not limit the scope of the invention. The drawings are not to scale (unless so stated) and are intended for use in conjunction with the explanations in the following detailed description. Embodiments will hereinafter be described in conjunction with the appended drawings wherein like numerals denote like elements, and:



FIG. 1 is a schematic diagram showing an exemplary dual chamber intra-cardiac pacing device implanted in a right side of a heart;



FIG. 2A is a plan view of a relatively compact dual chamber intra-cardiac pacing device, according to some embodiments;



FIG. 2B is a schematic section showing an atrial portion of the device of FIG. 2A implanted, according to some embodiments and methods;



FIG. 3A is an elevation view of an exemplary fixation component which may be employed by the atrial portion of the device, according to some embodiments;



FIG. 3B is a perspective view of the component of FIG. 3A, according to some embodiments;



FIG. 3C is a plan view of a portion of the component of FIGS. 3A-B, prior to forming, according to some embodiments;



FIG. 3D is a plan view of a portion of the component of FIGS. 3A-B, prior to forming, according to some alternate embodiments;



FIG. 4A is a plan view, with a partial cut-away section, of an interventional medical system, according to some embodiments;



FIG. 4B is a cross-section view through section line B-B of FIG. 4A, according to some embodiments;



FIG. 5A is a schematic diagram of the system of FIG. 4A advanced into a right ventricle for deployment of a ventricular portion of the device of FIG. 2A;



FIG. 5B is a schematic diagram of a delivery tool of the system positioned in a right atrium for deployment of the atrial portion of the device;



FIG. 5C is a cross-section view through a distal end of a delivery tool of the system, according to some embodiments;



FIG. 6A is a schematic showing a spring loaded condition of the fixation component of the atrial portion of the device, according to some embodiments;



FIG. 6B is a schematic showing an initial release of the fixation component from the spring loading shown in FIG. 6A;



FIG. 6C is a schematic showing rotation for initial penetration of the fixation component after the initial release of FIG. 6B;



FIG. 6D is a schematic showing fixation component movement, subsequent to initial penetration;



FIG. 6E is a schematic showing fixation component movement, subsequent to penetration;



FIG. 6F is a schematic showing fixation component movement, subsequent to penetration;



FIG. 7A is a plan view of a distal portion of an alternate embodiment of a portion of the system shown in FIG. 4A



FIG. 7B is an end view of the distal portion of FIG. 7A;



FIG. 8A is a plan view, with a partial cut-away section, of a portion of an interventional medical system, according to some alternate embodiments;



FIG. 8B is an end view of an inner assembly of a delivery tool of the system of FIG. 8A, according to some embodiments;



FIG. 8C is an exemplary cross-section view through the inner assembly, according to some embodiments;



FIG. 8D is a plan view of the system of FIG. 8A, according to some embodiments;



FIGS. 8E-F are longitudinal cross-section views through portions of the system, the general locations of which are indicated in FIG. 8D, according to some embodiments;



FIG. 9A is a schematic diagram of the system of FIGS. 8A-E advanced into a right ventricle for deployment of a ventricular portion of the device of FIG. 2A, according to some methods;



FIG. 9B is a schematic diagram of a delivery tool of the system positioned in a right atrium for deployment of the atrial portion of the device, according to some methods;



FIG. 9C is a plan view, with a partial cut-away section, of a portion of the interventional medical system of FIGS. 8A-E, according to some embodiments;



FIG. 10A is a schematic diagram related to some retrieval methods with a delivery tool described in conjunction with FIGS. 4A-B;



FIG. 10B is a schematic diagram related to some retrieval methods with the delivery tool described in conjunction with FIGS. 8A-F; and



FIG. 11 is a schematic diagram related to an alternate deployment method.





DETAILED DESCRIPTION

The following detailed description is exemplary in nature and is not intended to limit the scope, applicability, or configuration of the invention in any way. Rather, the following description provides practical examples, and those skilled in the art will recognize that some of the examples may have suitable alternatives.



FIG. 2A is a plan view of a relatively compact dual chamber intra-cardiac pacing device 1200, according to some embodiments. FIG. 2A illustrates device 1200 including a ventricular portion 100, an atrial portion 200, and a flexible leadlet 120 that connects ventricular portion 100 to atrial portion 200. Ventricular portion 100 is shown including a hermetically sealed housing 105, preferably formed from a biocompatible and biostable metal such as titanium, which contains a pulse generator (e.g., a power source and an electronic controller—not shown), a plurality of fixation tines 103, and an electrode 106, for example, being coupled to the pulse generator by a conductor of an hermetic feedthrough assembly (not shown) that is constructed according to methods known to those skilled in the art of implantable medical devices. Housing 105 may be overlaid with an insulative layer, for example, medical grade polyurethane, parylene, or silicone, and another electrode 107 may be formed by removing a portion of the insulative layer to expose the metallic surface of housing 105. According to the illustrated embodiment, electrode 106 may function for bipolar pacing and sensing, in conjunction with electrode 107, when elastically deformable fixation tines 103 hold electrode 106 in intimate tissue contact at a target implant site, for example, within right ventricle RV as illustrated schematically in FIG. 1. Exemplary embodiments of fixation tines 103 are described in commonly assigned U.S. Pat. No. 9,155,882, which is hereby incorporated by reference in its entirety.


With further reference to FIG. 2A, atrial portion 200 includes a core 250 that extends from a first end 201 thereof to a second end 202 thereof, along a longitudinal axis 2 of atrial portion 200, and to which another electrode 206 is mounted, in proximity to second end 202. Leadlet 120 is shown extending from a proximal end 101 of device ventricular portion 100 to first end 201 of core 250. According to the illustrated embodiment, a conductor 122 (FIG. 4B) of leadlet 120, which extends through another hermetic feedthrough assembly (not shown) of ventricular portion 100, and within an insulative tubular member 121 of leadlet 120, electrically couples the aforementioned pulse generator (contained within housing 105) to electrode 206. Conductor 122 may be formed by one or more wires, for example, MP35N alloy known to those skilled in the art, in a coiled or cabled configuration; and insulative tubular member 121 may be any suitable medical grade polymer, for example, polyurethane, silicone rubber, or a blend thereof. Core 250 may be formed from any suitable medical grade polymer, such as, polyurethane, silicone, polyethylene, or polyether ether ketone (PEEK), for example, being insert molded around a shank (not shown) of electrode 206, to which conductor 122 is coupled. According to an exemplary embodiment, a length of flexible leadlet 120, from proximal end 101 of ventricular portion housing 105 to first end 201 of atrial portion core 250 is in a range from about 15 cm to about 20 cm. It should be noted that, according to some alternate embodiments, atrial portion 200 includes another electrode mounted to core 250 and spaced apart from electrode 206, toward first end 201, to provide bipolar pacing and sensing in right atrium RA. In this case, leadlet 120 includes a pair of conductors isolated from one another, to electrically couple each atrial electrode to the pulse generator.



FIG. 2A further illustrates atrial portion 200 including a plurality of elastically deformable fixation tines 303 spaced apart around a perimeter of core 250 and being fixedly mounted thereto, for example, via a base 301 to which each tine 303 is joined, as described below in conjunction with FIGS. 3A-B. According to the illustrated embodiment, elastically deformable fixation tines 303 hold electrode 206 of atrial portion 200 in intimate tissue contact at a target implant site within right atrium RA, for example, as illustrated schematically in FIG. 2B. In FIG. 2A, one of tines 303 is shown divided into first, second, and third segments S1, S2, S3, each of which is pre-formed into, and elastically deformable from, the illustrated shape thereof. According to the illustrated embodiment, each first segment S1 is fixedly attached to core 250, and extends around a pre-formed curvature to the corresponding second segment S2, which extends proximally along a relatively straight line to the corresponding third segment S3. FIG. 2A illustrates third segment S3 extending around a pre-formed curvature to a free distal end 352 of tine 303.



FIG. 2B is a schematic section showing atrial portion 200 of device 1200 implanted in right atrium RA, according to some embodiments and methods. With reference to FIG. 2B, a portion the right atrial wall, for example, in appendage 102 (FIG. 1), is shown having a laminate structure that includes an inner layer of pectinate muscle PM and an outer layer of visceral pericardium VP, which forms the epicardial surface. FIG. 2B illustrates atrial portion 200 secured at the implant site by fixation tines 303 penetrating through the layer of pectinate muscle PM without perforating through visceral pericardium VP, which could result in pericardial effusion. Tines 303, according to embodiments disclosed herein, are configured for spring-loaded release when atrial portion 200 of device 1200 is deployed out through a distal opening of a delivery tool, for example, a distal opening 403 of a lumen 435 of a delivery tool 400 in an interventional medical system 1240 (FIGS. 4A-B), or a distal opening 802 of a lumen 825 of a delivery tool 800 of a system 8280 (FIGS. 8A-E). In either case, upon release of the spring loading, tine free distal end 352 penetrates pectinate muscle PM without perforating visceral pericardium VP. It should be noted that alternate suitable implant sites for embodiments of fixation member tines described herein can be along any endocardial surface defined by pectinate muscle PM. The spring-loaded release and exemplary methods for deploying device 1200 are described below in conjunction with FIGS. 4A-B, 5A-B, 6A-F, 7A-B, 8A-E, and 9A-C. However, implantable medical devices having alternative tine configurations, for example, those more suitable for fixation to endocardial surfaces where pectinate muscle PM is not present, can be employed by the systems and methods described below, and such systems and methods are not outside the scope of the present invention.



FIGS. 3A-B are elevation and perspective views of a fixation component 300 that forms the fixation mechanism for atrial portion 200 of device 1200, according to some embodiments. FIGS. 3A-B illustrate the aforementioned base 301 from which a plurality of tines 303 extend, being spaced apart from one another around a perimeter of base 301. Tines 303 are shown in a relaxed, or pre-formed spring-biased condition. In FIG. 3A, a longitudinal axis 3 of component 300 is shown being defined by base 301 such that, when base 301 is mounted around atrial portion core 250, and a perimeter of component 300 extends around electrode 206, axis 3 is generally aligned along longitudinal axis 2 of atrial portion 200 (FIG. 2A). With reference to FIG. 3B, base 301 is shown including an inward bending segment 310 directed toward axis 3 between each adjacent pair of tines 303. With reference back to FIG. 2A, when component 300 is mounted on core 250 of device atrial portion 200, each of inward bending segments 310 may provide clearance for a groove, or open channel 253 of atrial portion 200, which can be a molded feature of core 250. Core 250 may be inserted molded around component 300, or component 300 may be snap fit, staked or bonded to a separately-molded core 250, according to methods known in the art. (However, in some alternate embodiments, tines 303 may be individually mounted to core 250 without being integrated together by any base.) FIG. 2A illustrates channel 253 extending between first and second ends 201, 202 of core 250. According to the illustrated embodiment, channel 253 is sized to receive leadlet 120 therein, for example, to provide clearance for leadlet 120 to extend alongside core 250 within delivery tool 400, as will be described below in conjunction with FIGS. 4A-B. Although only one channel 253 is shown in FIG. 2A, some embodiments of core 250 include a plurality of channels 253, for example, one between each adjacent pairs of tines 303, as shown in FIG. 4B.


Tines 303 are preferably formed from a super-elastic material, for example, a Nickel-Titanium alloy (Nitinol). Fixation component 300 may be cut from a medical grade Nitinol tubing that conforms to the chemical, physical, mechanical, and metallurgical requirements of the ASTM F2063 standard, and has a wall thickness of about 0.005 inch. In this case, tines 303 are integrally formed with base 301 and each tine 303 may have a constant thickness t of 0.005 inch±0.001 inch. After cutting the tubing, tines 303 and base 301 are formed into the configuration shown in FIGS. 3A-B by holding each in the illustrated shape, while heat treating according to methods known to those skilled in the art.



FIG. 3A illustrates each tine 303 including a proximal, spring portion 33, which corresponds to first segment S1 of FIG. 2A, and a distal portion 35, which corresponds to second and third segments S2, S3 of FIG. 2A, and which is terminated by free distal end 352. Free distal end 352 is preferably rounded, as shown in FIG. 3A. FIG. 3A further illustrates distal portion 35 including a proximal section 35-P, a hook section 35-H, and a tip section 35-T. The shaped configuration and width of each tine 303, along with the super-elastic stiffness properties of Nitinol, provide a sufficient spring force and structural stiffness for tines 303 to engage tissue for the fixation of device atrial portion 200 at an implant site when deployed by delivery tool 400 or delivery tool 800, as described in greater detail below. With reference to FIG. 3A, each tine 303 has a width w which is preferably no less than about 0.02 inch, for example, being in a range from about 0.025 inch to about 0.032 inch. Such a width provides the aforementioned structural stiffness, as well as a radiopaque density that facilitates fluoroscopic visualization during and after the implant procedure.


With further reference to FIG. 3A, according to the illustrated embodiment, each proximal, spring portion 33 is fixedly attached to base 301 and has a spring-biased pre-formed curvature, which, in proximity to the base, extends in a first direction d1, generally parallel to axis 3, and then sweeps laterally, outward from axis 3 to distal portion proximal section 35-P. Distal portion proximal section 35-P, according to the illustrated embodiment, is pre-formed to extend in a second direction d2 and along a relatively straight line (dashed line), being oriented, by the spring-biased pre-formed curvature of proximal, spring portion 33, so that second direction d2 is generally opposite first direction d1, and the relatively straight line intersects axis 3 at an acute angle θ. According to some embodiments, angle θ is between about 30 degrees and about 50 degrees. In an exemplary embodiment of component 300, to be employed by an exemplary embodiment of device 1200 in which atrial portion core 250 has an outer diameter of about 0.26 inch (20 French), the spring-biased pre-formed curvature of each proximal, spring portion 33 is defined by a single radius of 0.067 inch±0.010 inch; a distance A between base 301 and each intersection of proximal, spring portion 33 and distal portion proximal segment 35-P is 0.092 inch±0.005 inch; a length of each distal portion proximal segment 35-P is 0.100 inch±0.005 inch; and angle θ is about 45 degrees.


With further reference to FIG. 3A, each distal portion hook section 35-H has a deformable pre-formed curvature that extends from proximal, spring portion 33 back toward axis 3. FIG. 3A further illustrates tip section 35-T of distal portion 35 extending from hook section 35-H along a relatively straight line to rounded free distal end 352. Tip section 35-T is shown oriented by the pre-formed curvature of hook section 35-H, when un-deformed, to extend toward axis 3, such that tip section 35-T and proximal section 35-P are shown enclosing an angle φ, which, according to the illustrated embodiment, is no less than about 90 degrees, but can be up to about 120 degrees. In the aforementioned exemplary embodiment of component 300, the deformable pre-formed curvature of each hook section 35-H, when un-deformed, is defined by a single radius of about 0.05 inch; and a length of each tip section 35-T is 0.064 inch±0.005 inch.



FIGS. 3C-D are plan views of alternate tine embodiments prior to being formed into the configuration of FIG. 3A, wherein tine 303-105° of FIG. 3C is suitable for an exemplary component 300 in which angle φ is about 105 degrees, and wherein tine 303-90° of FIG. 3D is suitable for an exemplary component 300 in which angle φ is about 90 degrees. With further reference to FIGS. 3C-D, an exemplary width w of each tine 303 is 0.028 inch±0.001 inch, and, in the tine embodiment of FIG. 3C, rounded free distal end 352 of tine 303-105° has an enlarged width defined by a diameter of 0.030 inch±0.001 inch.



FIG. 4A is a plan view, with a partial cut-away section, of interventional medical system 1240, according to some embodiments, which includes device 1200 (FIG. 2A) and delivery tool, wherein device 1200 is shown loaded in delivery tool 400 for deployment; and FIG. 4B is a cross-section view through section line B-B of FIG. 4A, according to some embodiments. FIG. 4A illustrates tool 400 including a handle 410, an elongate outer member 430, and an elongate inner member 420, which extends within lumen 435 of outer member 430, and around which outer member 430 is slideably engaged, for example, via a control member 412 of handle 410, as described below. FIG. 4A further illustrates inner member 420 including a distal end 422, which is configured to engage device atrial portion 200 by abutting first end 201 of core 250. An entirety of device 1200 is shown loaded within a tubular sidewall 432 of outer member 430 that defines a distal portion of outer member lumen 435. With reference back to FIG. 2A, prior to loading device 1200 into delivery tool 400, atrial portion 200 is reoriented relative to ventricular portion 100 by bending leadlet 120, per arrow B, so that a first segment 12-1 of leadlet 120 extends within open channel 253 of core 250, so that a second segment 12-2, folded over on itself, extends within distal end 422 of inner member 420, and so that tines 303 are adjacent ventricular portion proximal end 101. To load device 1200 into tool 400, the operator may employ a tether 480 of tool 400 (seen in FIG. 4A) by engaging tether 480 around leadlet 120 at a zone 124 (FIG. 2A) that coincides with the aforementioned fold per arrow B. According to the illustrated embodiment, opposing lengths of tether 480 extend within lumens 425 of inner member 420 so that tether 480 loops around leadlet 120 for engagement therewith, and proximal ends 481 of the tether lengths protrude from a proximal port opening 415 of delivery tool 400, where an operator may grasp them. The operator may pull ends 481 of tether 480, to draw folded segment 12-2 of leadlet 120 in through a distal opening 403 of lumen 435, followed by atrial portion 200, with core first end 201 leading, and then followed by ventricular portion 100. FIG. 4A illustrates tether 480 looped around zone 124 such that folded second segment 12-2 of leadlet 120 extends within distal end 422 of inner member 420, when device 1200 is loaded in delivery tool 400, and, with reference to FIG. 4B, first segment 12-1 of leadlet 120 can be seen extending in one of a plurality of channels 253 of core 250, according to some embodiments. It should be noted that a snare-type tool, such as is known to those skilled in the art, may be employed in lieu of tether 480, such that the term “tether” may broadly refer to such a snare. According to the illustrated embodiment, an inner surface 42 of tubular sidewall 432 first engages fixation tines 303 of atrial portion 200, and then ventricular portion tines 103, as device 1200 is pulled into lumen 435, to deform each set of tines 103, 303, per arrows D1 and D2 (FIG. 2A), respectively, and to hold tines 103, 303 of the loaded device 1200 in a spring-loaded condition, for example, as shown in FIG. 4A. According to the above-described exemplary embodiments of fixation tines 303, when atrial portion core 250 and ventricular portion housing 105 are each sized to an outer diameter of about 0.26 inch (20 French), a diameter of lumen 435, defined by inner surface 42, is about 0.28 inch (21 French). In alternate embodiments, described below, starting with FIG. 8A, an implantable device includes an atrial portion that is downsized relative to the ventricular portion. With further reference to FIG. 4A, a proximal end of outer member 430 is coupled to control member 412 of handle 410 such that an entirety of outer member 430 is movable with respect to inner member 420, via control member 412; thus, an operator may retract outer member 430, per arrow W, relative to device 1200 and inner member 420, to deploy device 1200 out through distal opening 403. According to the illustrated embodiment, and with reference back to FIG. 1, the operator first deploys ventricular portion 100 of device 1200 at an implant site in right ventricle RV of the patient, and then deploys atrial portion 200 at an implant site in right atrium RA of the patient.



FIG. 5A is a schematic diagram of system 1240 within right ventricle RV, after the operator has deployed ventricular portion 100. According to some methods, the operator deploys ventricular portion 100 by advancing system 1240 through a venous system of the patient, for example, from a femoral venous access site and up through an inferior vena cava IVC of the patient into right atrium RV and across the tricuspid valve into right ventricle RV, until a distal end 43 of delivery tool 400 abuts the target implant site. With distal end 43 abutting the implant site, the operator applies a push force through tool 400 while retracting outer member 430, as described above, to release fixation tines 103 of ventricular portion 100 out through distal opening 403 for engagement with tissue at the implant site. With reference back to FIG. 4A, the abutment of inner member 420 against first end 201 of core 250 of device atrial portion 200, and the abutment of tine tip sections 35-T of atrial portion 200 against proximal end 101 of device ventricular portion 100 together apply pressure to stabilize ventricular portion 100 as the operator withdraws outer member 430. With reference to FIG. 5A, once fixation tines 103 of ventricular portion 100 are completely released from the spring-loaded condition, for full engagement with tissue at the implant site, the operator withdraws, per arrow E, delivery catheter 400, with atrial portion 200 still contained therein, back into right atrium RA, while first segment 12-1 and second segment 12-2 of leadlet 120 slide through channel 253 of atrial portion core 250 and out through distal opening 403 of outer member 430.



FIG. 5B is a schematic diagram of delivery tool 400 positioned in right atrium RA for deployment of device atrial portion 200. FIG. 5B illustrates distal opening 403 of outer member 430 directed into atrial appendage 102 where the operator will abut distal end 43 against pectinate muscle PM (FIG. 2B) and apply a push force through delivery tool 400 prior to retracting outer member 430, relative to inner member 420 and atrial portion 200, to release the spring loading of fixation tines 303 for engagement with pectinate muscle PM at the implant site, as shown in FIG. 2B. FIG. 5C is a cross-section view through distal end 43 of delivery tool 400 showing atrial portion 200 positioned for deployment. With reference to FIG. 5C, it may be appreciated that tether 480 was free to move distally, as the operator retracted delivery tool 400 from right ventricle RV into right atrium RA, and leadlet first and second segments 12-1, 12-2 slid out through distal opening 403. FIG. 5C illustrates a third segment 12-3 of leadlet extending within channel 253 of core 250, and distal portion tip section 35-T of spring-loaded tines 303 located in close proximity to distal opening 403. (Leadlet third segment 12-3 is also shown in FIG. 2A, for reference.) The spring loaded condition of tines 303 is described in greater detail below, in conjunction with FIG. 6A.


Delivery tool 400 may include articulating features to facilitate the above-described navigation. For example, inner member 420 of delivery tool 400 may include a pull wire assembly (not shown) integrated therein. With reference back to FIG. 4A, the pull wire assembly may be coupled to another control member 411 of handle 410 that, when moved per arrow A, causes inner member 420 and outer member 430 to bend along distal portions thereof. A length of outer member 430, between handle 410 and distal opening 403, when outer member 430 is in the position shown in FIG. 4A, may be about 110 cm, for example, to reach into the right ventricle RV from the femoral access site. Suitable construction detail for a delivery tool like tool 400 is described in co-pending and commonly assigned U.S. Patent Application 2015/0094668, Ser. No. 14/039,937; (filed on Sep. 27, 2013), the description of which is hereby incorporated by reference. However, it should be noted that, according to some alternative embodiments and methods, delivery tool 400 may be configured so that an operator can move inner member 420 relative to outer member 430 to deploy one or both of ventricular and atrial portions 100, 200 of device 1200 out through distal opening 403, and, in these embodiments, inner member 420 and/or outer member 430 may include a pull wire assembly to facilitate navigation.



FIGS. 6A-F are schematics outlining a sequence of events corresponding to the release of the spring loading for above-described embodiments of fixation tines 303 for device atrial portion 200. (Although the schematics show tines 303 integrally formed with base 301, as in above-described embodiments of component 300, it should be understood that the sequence of events in FIGS. 6A-F may also apply to alternate embodiments in which tines 303 are not integrally formed with base 301.) FIG. 6A illustrates a maximum deformation of tines 303 when held in the spring-loaded condition by the engagement of rounded free distal end 352 with inner surface 42 of outer member tubular sidewall 432, wherein proximal, spring portion 33 becomes relatively straightened, and a location of the maximum principle strain along each tine 303 is in relatively close proximity to base 301 (designated by dashed-line circle). With reference back to FIG. 3A, the aforementioned exemplary length of distal portion tip section 35-T and the aforementioned associated angle φ (no less than 90 degrees) help to keep the deformed tines 303 from touching one another within lumen 435 and to prevent free distal ends 352 from being pulled proximally, per arrow P, when outer member 430 is retracted to release the spring loading of tines 303. FIG. 6A further illustrates tip section 35-T extending away from axis 3 at an acute angle δ, which is preferably in a range from about 45 degrees to about 75 degrees for an initial release of the spring loading of each tine 303, upon retraction of outer member 430, as depicted in FIG. 6B. With reference to FIG. 6C, once free distal end 352 is released from engagement with inner surface 42 for deployment into tissue at the implant site, the spring force of proximal, spring portion 33 and the pre-formed curvature of distal portion hook section 35-T cause distal portion tip section 35-T to immediately rotate away from axis 3 to an angle π, which approaches 90 degrees, so that tip section 35-T is oriented approximately normal to axis 3 for initial penetration of pectinate muscle PM. Thus each tine free distal end 352 is deployed in a direction toward pectinate muscle PM that ultimately prevents tines 303 from perforating the underlying visceral pericardium VP (reference FIG. 2B). FIGS. 6D-F illustrates the subsequent movement of tines 303, being driven by the release of proximal, spring portion 33 from the spring loading. According to the illustrated embodiment, this release of proximal, spring portion 33 causes free distal end 352, after penetrating through pectinate muscle PM in a first direction, at a first location P1, to penetrate back through in an opposite direction, at a second location P2, so that device 20 may be securely fixed at the implant site, as illustrated in FIG. 2B.


The configuration of tine distal portion 35, for example, embodied by the aforementioned exemplary lengths of proximal section 35-P and tip section 35-T, and the pre-formed curvature of hook section 35-H, provide a structural stiffness and reach to each tine 303 that is sufficient for deformation and subsequent penetration of free distal end 352 through pectinate muscle PM, as shown in FIG. 2B, but is not sufficient for penetration through visceral pericardium VP. Even if the operator ends up advancing the system into appendage 102 so that distal opening 403 of tool 400 abuts visceral pericardium VP, between folds of pectinate muscle PM, free distal end 352, according to this configuration of tines 303, is not backed-up by sufficient stiffness to penetrate through visceral pericardium VP, so tip section 35-T of tine distal portion 35 is redirected, laterally, toward pectinate muscle PM.


It should be noted that an operator may employ fixation component 300 to secure atrial portion 200 in atrial appendage 102 in an alternative fashion, wherein tines 303 are fully released from the spring-loaded condition without engaging any tissue (FIG. 6F), and then atrial portion 200 is advanced to the implant site so that tines 303 wedge between opposing surfaces of pectinate muscle PM within atrial appendage 102.


With reference back to FIGS. 2A-B, according to some embodiments, for example, in order to assure intimate contact of electrode 206 with tissue, when fixation component 300 secures atrial portion 200 at a target implant site, electrode 206 is spaced distally apart from second end 202 of atrial portion core 250 by a distance along longitudinal axis 2. Electrode 206 may be approximately flush with an intersection between proximal, spring portion 33 and distal portion 35, or spaced distally apart from the intersection by a distance X that may be up to about 2 mm, as depicted in FIG. 2A.


With reference back to FIG. 5C, the position of leadlet 120, in proximity to distal opening 403 of delivery tool 400, may interfere with tines 303, when tip segments 35-T thereof are positioned for release out through distal opening 403. FIGS. 7A-B are a plan view and an end view of a distal portion of tool 400 including an alternate embodiment outer member 730 (in lieu of outer member 430), in which a slot 73-S is formed in a sidewall 732 of outer member 730. Sidewall 732, similar to sidewall 432 of outer member 430, defines a lumen 735 of outer member 730, in which inner member 420 is slideably engaged, and which has a distal portion sized to contain device 1200 in a similar fashion to that described above for lumen 435 of outer member 430 (FIG. 4A). FIG. 7A illustrates slot 73-S extending proximally from an open end thereof, which coincides with a distal opening 703 of lumen 735. FIGS. 7A-B illustrate leadlet 120 passing laterally out through slot 73-S, when tip segments 35-T of tines 303 are positioned in proximity to distal opening 703, for example, after ventricular portion 100 has been deployed. According to the illustrated embodiment, slot 73-S allows leadlet 120 to move laterally away from tines 303 of atrial portion 200 prior to the deployment of atrial portion 200 out through distal opening 703, for example, to prevent leadlet 120 from becoming trapped against tissue at the implant site when tines 303 are released from spring loading for engagement with the tissue.


Device 1200 may be loaded into outer member 730 in a similar fashion to that described above for loading device 1200 into outer member 430. But, with further reference to FIG. 7B, it may be appreciated that care must be taken when drawing atrial portion 200 into lumen 735 through distal opening 703, to load device 1200 into outer member 730, so that none of tines 303 catch in slot 73-S, and so free distal end 352 of each tine tip segment 35-T rests against a location on an inner surface 72 of sidewall 732 that is circumferentially offset from slot 73-S.


According to some alternate embodiments, atrial portion 200 of device 1200 may be downsized relative to ventricular portion 100 of device 1200, and included with delivery tool 800 in a system 8280, portions of which are shown in FIGS. 8A-F. FIG. 8A illustrates such a device 1200 prior to loading into delivery tool 800; and FIGS. 8D-F illustrate system 8280 with device 1200 loaded in delivery tool 800. Delivery tool 800 includes an elongate outer member 830 and an inner assembly 850. Inner assembly 850, which is slideably engaged within a lumen 835 of outer member 830 (FIGS. 8D-F), is shown protruding distally from a distal opening 803 of lumen 835 in FIG. 8A. FIG. 8A further illustrates inner assembly 850 including an elongate inner member 820, an elongate sheath 810, which is slideably engaged within lumen 825 of inner member 820, and a tether 880, which is engaged with leadlet 120 of device 1200, being looped thereabout. According to the illustrated embodiment, sheath 810 includes side-by-side longitudinally extending lumens 815 that have openings located at a distal-facing surface 81 of sheath 810, and opposing lengths of tether 880 extend within lumens 815 of sheath 810 to form the loop that engages leadlet 120 in proximity to distal-facing surface 81; and proximal ends 881 of these tether lengths, which may be seen in FIG. 8D, protrude from a proximal port opening of delivery tool 800 where an operator may grasp them. With further reference to FIG. 8A, in conjunction with FIG. 2A, leadlet 120 is folded over on itself along third segment 12-3 for engagement with the loop of tether 880, for example, such that the bend thereof that is engaged by the tether loop is spaced about one inch apart from first end 201 of atrial portion core 250. According to the illustrated embodiment, tether 880 together with sheath 810 may be employed to pull atrial portion 200 of device 1200, per arrow Q, into lumen 825 of inner member 820 so that atrial portion 200 is contained in lumen 825 and tines 303 of atrial portion 200 are spring-loaded, as shown in FIG. 8F, with free distal ends 352 of tip segments 35-T resting against an inner surface 823 of a sidewall 822 of inner member 820 that defines lumen 825. Subsequently, after sheath 810 has been pulled proximally within lumen 825 of inner member 820, until leadlet 120 is contained therein and a distal end 82 of inner member 820 abuts proximal end 101 of ventricular portion housing 105, outer member 830 may be advanced relative to inner assembly 850 so that a distal end 83 of outer member 830 contains ventricular portion 100 of device 1200, as shown in FIG. 8E. It should be noted that tether 880 and sheath 810 may be in the form of any suitable snare-type tool, known to those skilled in the art.



FIG. 8A further illustrates sidewall 822 of inner member 820 having a slot 82-S formed therein along distal end 82 thereof, wherein slot 82-S extends proximally from an open end thereof, which coincides with a distal opening 802 of lumen 825. Slot 82-S, similar to slot 73-S described above for outer member 730, allows leadlet 120 to move laterally away from tines 303 of atrial portion 200 prior to the deployment of atrial portion 200 out through distal opening 802, for example, to prevent leadlet 120 from becoming trapped against tissue at the implant site when tines 303 are released from spring loading for engagement with the tissue. The deployment of atrial portion 200, according to some methods, is described below in conjunction with FIG. 9B.


It may be appreciated that care must be taken, when drawing atrial portion 200 into lumen 825 through distal opening 803, so that none of tines 303 catch in slot 73-S. Thus, with reference to FIG. 8B, which is an end view of inner assembly 850, an orientation guide for atrial portion 200 may be included in inner assembly 850. FIG. 8B illustrates the loop of tether 880 spanning lumens 815 and extending over a groove 811, which is formed in distal-facing surface 81 of sheath 810 as the orientation guide. According to the illustrated embodiment, groove 811 is sized to receive third segment 12-3 of leadlet 120, so that, by positioning folded third segment 12-3 in groove 811, the operator can orient atrial portion 200 with tines 303 circumferentially offset from slot 82-S, when pulling atrial portion 200 into distal end 82 of inner member 820. (The resulting position of tines is shown with dashed lines in FIG. 8B.) In some embodiments, an outer surface of sheath 810 may interlock with inner surface 823 of inner member 820, for example, via an optional interlocking spline configuration shown in the exemplary cross-section of FIG. 8C, to keep sheath 810 and member 820 in a predetermined circumferential orientation with respect to one another, for example, the orientation shown in FIG. 8B.


With further reference to FIG. 8D, general relative locations of ventricular portion 100 and atrial portion 200 are indicated when device 1200 is loaded into delivery tool 800 for deployment, for example, being spaced about 15 cm to 20 cm apart from one another, which corresponds to the aforementioned exemplary length of flexible leadlet 120. FIGS. 9A-C outline some exemplary methods for deploying device 1200 from delivery tool 800. Like tool 400, described above, tool 800 may have a length of approximately 110 cm to reach into right ventricle RV. Furthermore, delivery tool 800 may include articulating features to facilitate the navigation thereof as described below. For example, outer member 830 may include a pull-wire assembly integrated therein, according to construction features known to those skilled in the art.



FIG. 9A is a schematic diagram of delivery tool 800 positioned within right ventricle RV, after the operator has deployed ventricular portion 100. According to some methods, the operator deploys ventricular portion 100 by advancing tool 800 through a venous system of the patient, for example, from a femoral venous access site and up through an inferior vena cava IVC of the patient into right atrium RA and across the tricuspid valve into right ventricle RV, until distal opening 803 of delivery tool 800 abuts the target implant site. With distal opening 803 abutting the implant site, the operator applies a push force through tool 800 while retracting outer member 830 relative to inner assembly 850 and device 1200 (arrow W of FIG. 8E), to release fixation tines 103 of ventricular portion 100 out through distal opening 803 for engagement with tissue at the implant site, as shown in FIG. 9A. With reference back to FIG. 8E, the abutment of inner member distal end 82 against ventricular portion proximal end 101 applies pressure to stabilize ventricular portion 100 as the operator retracts outer member 830. Once ventricular portion 100 is deployed, the operator may withdraw outer member 830 and inner member 820, relative to sheath 810 and tethered device 1200, back up into right atrium RA (arrow E of FIG. 9A) in order to deploy atrial portion 200.



FIG. 9B is a schematic diagram of delivery tool 800 positioned in right atrium RA for deployment of device atrial portion 200. FIG. 9B illustrates distal end 82 of inner member 820 still protruding distally from distal opening 803 of outer member 830 and directed into atrial appendage 102, where the operator will abut distal end 82 against pectinate muscle PM (FIG. 2B) for deployment of atrial portion 200 at a target implant site. FIG. 9B further illustrates a length of leadlet 120 that has passed out from inner member 820 as the operator withdrew outer member 830 and inner member 820 into right atrium RA. With reference to the cross-section view in FIG. 9C, atrial portion 200 and distal-facing surface 81 of sheath 810 also became located in closer proximity to distal opening 802 of inner member 820, as the operator withdrew outer member 830 and inner member 820 into right atrium RA. With distal opening 802 of inner member 820 abutting pectinate muscle PM, the operator may apply a push force to atrial portion 200, through sheath 810, per arrow F, to release the spring loading of fixation tines 303 for engagement with pectinate muscle PM at the implant site, as shown in FIG. 2B. (Note that FIGS. 6A-F, and the corresponding description thereof, may also pertain to the release of tines 303 from inner member 820.) FIG. 9C further illustrates leadlet 120 extending laterally away from atrial portion 200, as allowed by slot 82-S (FIG. 8A), when atrial portion 200 is positioned for deployment; thus, leadlet 120 will not become trapped against tissue at the implant site, when tines 303 are released from spring loading for engagement with the tissue.


Once ventricular portion 100 and atrial portion 200 of device 1200 are both deployed at respective implant sites, by any of the above-described delivery tools 400, 800, tether 480, 880 may be released from leadlet 120 of device 1200, for example, by pulling one of tether ends 481, 881 proximally from the corresponding lumen 425, 815, to unloop tether 480, 880. However, before unlooping tether 480, 880, if the operator determines that device 120 needs to be retrieved, for example, for repositioning, tether 480, 880 may be employed to disengage, and reload into tool 400, 800, atrial portion 200 followed by ventricular portion 100 of device 1200. FIGS. 10A-B are schematic diagrams related to some retrieval methods. FIG. 10A shows delivery tool 400 positioned relative to flexible leadlet 120 and the loop of tether 480 advanced distally out from inner member 420 to cinch around leadlet 120, preferably at the aforementioned zone 124 (FIG. 2A) so that, in retrieving device, leadlet 120 can be folded at the same location at which it was initially folded for loading, as described above in conjunction with FIGS. 2A and 4A. According to some preferred embodiments, a radiopaque marker may be coupled to leadlet 120 at zone 124 so the operator can locate zone 124 under fluoroscopy. FIG. 10B shows delivery tool 800 positioned relative to flexible leadlet 120, and the loop of tether 880 advanced out from sheath 810 to cinch around leadlet 120 along third segment 12-3, for example, at the preferred location described above for loading atrial portion 200 into delivery tool 800, about one inch away from atrial portion core 250.


Finally, in some alternative methods, an operator may choose to initially load device 1200 into a delivery tool, for example, tool 800 described above, so that the orientation of the loaded ventricular and atrial portions 100, 200 are as shown in FIG. 2A, without flexible leadlet 120 being folded over on itself, and without tines 303 of atrial portion 200 being spring-loaded in the delivery tool. If so, after deploying ventricular portion 100 to the implant site in right ventricle RV, as shown in FIG. 9A, the operator can retract an entirety of delivery tool 800, per arrow E, until atrial portion 200 exits distal opening 802 of inner member 820. Then, the operator may advance sheath 810 with respect to inner member 820 until tether 880 extends out from distal opening 802, as shown in FIG. 11, and maneuver tether 880 to loop around leadlet 120 in proximity to atrial portion 200. Once tether 880 is secured around leadlet 120, the operator may pull, per arrow Q (FIG. 8A), atrial portion 200 into lumen 825 of inner member 820 so that tines 303 are spring-loaded, as shown in FIG. 9C, and then position tool 800 in right atrium RA to deploy atrial portion 200 at the target implant site, for example, in the same manner as was described above in conjunction with FIG. 9B. With further reference to FIG. 11, an enlarged perspective view of inner member distal end 82 is shown, wherein, according to some embodiments, distal end 82 is terminated by a beveled edge 82-B, for example, to facilitate the passage of leadlet 120 into slot 82-S when the operator pulls atrial portion 200 into lumen 825.


In the foregoing detailed description, specific exemplary embodiments have been described. However, it may be appreciated that various modifications and changes can be made without departing from the scope of the invention as set forth below.

Claims
  • 1. A tissue penetrating fixation component for an implantable medical device, the component comprising: a base defining a longitudinal axis of the component and being configured to be fixedly attached to the device so that a perimeter of the component extends around an electrode of the device, and so that the longitudinal axis of the component is generally aligned along a longitudinal axis of the device, the base including at least one inward bending segment defining a groove extending parallel to the longitudinal axis of the component, the inward bending segment being directed toward the axis; anda plurality of tines extending from the base and being spaced apart from one another around a perimeter thereof such that each of the at least one inward bending segment of the base is located between adjacent pairs of tines.
  • 2. The component of claim 1, wherein each tine comprises: a proximal, spring portion being fixedly attached to the base and having a spring-biased pre-formed curvature, the pre-formed curvature, in proximity to the base, extending in a first direction, generally parallel to the axis of the component, and then sweeping laterally, outward from the axis; anda distal portion including a proximal section, a hook section, and tip section terminated by a rounded free distal end, the proximal section extending from the proximal, spring portion and being pre-formed to extend in a second direction and along a relatively straight line to the hook section, the proximal section being oriented, by the spring-biased pre-formed curvature of the proximal, spring portion, so that the second direction is generally opposite the first direction, and the relatively straight line intersects the axis at an acute angle of between about 30 degrees and about 50 degrees, the hook section having a deformable pre-formed curvature that extends from the proximal section back toward the axis of the component, the tip section being pre-formed to extend along a relatively straight line from the hook section to the rounded free distal end, and the tip section being oriented, by the pre-formed curvature of the hook section, when un-deformed, to extend toward the axis of the component, such that the tip section and the proximal section enclose an angle in a range from about 90 degrees to about 120 degrees; andwherein, when the device, having the fixation component fixedly attached thereto, is loaded within a tubular sidewall of a delivery tool, so that the rounded free distal end of each tine of the component engages an inner surface of the sidewall, to hold the proximal, spring portion of each tine of the component in a spring-loaded condition, each tip section of the distal portion extends away from the axis of the component at an acute angle in a range from about 45 degrees to about 75 degrees for deployment of the corresponding rounded free distal end out from the tool tubular sidewall; andupon deployment of the rounded free distal end of each tine, the tip section of each distal portion rotates away from the axis to an angle that approaches 90 degrees, relative to the axis, in response to an initial release of the spring-loaded condition of the corresponding proximal, spring portion.
  • 3. The component of claim 1, wherein the base and the plurality of tines are integrally formed.
  • 4. The component of claim 1, wherein the base and the plurality of tines are formed from a medical grade super-elastic metal.
  • 5. The component of claim 1, wherein the base and the plurality of tines are integrally formed from medical grade Nitinol tubing.
  • 6. The component of claim 1, wherein each tine comprises: a proximal, spring portion being fixedly attached to the base and having a spring-biased pre-formed curvature, the pre-formed curvature, in proximity to the base, extending in a first direction, generally parallel to the axis of the component, and then sweeping laterally, outward from the axis; anda distal portion including a proximal section, a hook section, and tip section terminated by a rounded free distal end, the proximal section extending from the proximal, spring portion and being pre-formed to extend in a second direction and along a first relatively straight line to the hook section, the proximal section being oriented, by the spring-biased pre-formed curvature of the proximal, spring portion, so that the second direction is generally opposite the first direction, the hook section having a deformable pre-formed curvature that extends from the proximal section back toward the axis of the component, the tip section being pre-formed to extend along a second relatively straight line from the hook section to the rounded free distal end, and the tip section being oriented, by the pre-formed curvature of the hook section, when un-deformed, to extend toward the axis of the component.
  • 7. The component of claim 6, wherein the first relatively straight line intersects the axis at an acute angle of between about 30 degrees and about 50 degrees.
  • 8. The component of claim 6, wherein the tip section and the proximal section enclose an angle in a range from about 90 degrees to about 120 degrees.
  • 9. The component of claim 6, wherein, when the device, having the fixation component fixedly attached thereto, is loaded within a tubular sidewall of a delivery tool, so that the rounded free distal end of each tine of the component engages an inner surface of the sidewall, to hold the proximal, spring portion of each tine of the component in a spring-loaded condition, each tip section of the distal portion extends away from the axis of the component at an acute angle for deployment of the corresponding rounded free distal end out from the tool tubular sidewall.
  • 10. The component of claim 9, wherein the acute angle is in a range from about 45 degrees to about 75 degrees.
  • 11. The component of claim 9, wherein, upon deployment of the rounded free distal end of each tine, the tip section of each distal portion rotates away from the axis to an angle that approaches 90 degrees, relative to the axis, in response to an initial release of the spring-loaded condition of the corresponding proximal, spring portion.
  • 12. The component of claim 9, wherein the groove of the inward bending segment is sized to receive a leadlet of the device.
CROSS-REFERENCE TO RELATED APPLICATIONS

The instant application claims priority to U.S. Provisional Patent Application having the same title, the Ser. No. 62/281,312, which was filed on Jan. 21, 2016, and which is hereby incorporated by reference in its entirety. The instant application is also related to the U.S. patent application Ser. No. 15/410,161 and entitled, INTERVENTIONAL MEDICAL DEVICES, DEVICE SYSTEMS, AND FIXATION COMPONENTS THEREOF, which is filed concurrently herewith.

US Referenced Citations (301)
Number Name Date Kind
721869 Dunning Mar 1903 A
3717151 Collett Feb 1973 A
3754555 Schmitt Aug 1973 A
3814104 Irnich et al. Jun 1974 A
3835864 Rasor et al. Sep 1974 A
3902501 Citron et al. Sep 1975 A
3943936 Rasor Mar 1976 A
3971364 Fletcher et al. Jul 1976 A
3976082 Schmitt Aug 1976 A
4103690 Harris Aug 1978 A
4112952 Thomas et al. Sep 1978 A
4269198 Stokes May 1981 A
4280512 Karr Jul 1981 A
4301815 Doring Nov 1981 A
4402328 Doring Sep 1983 A
4409994 Doring Oct 1983 A
4502492 Bornzin Mar 1985 A
4662382 Sluetz et al. May 1987 A
4898577 Badger et al. Feb 1990 A
4913164 Greene et al. Apr 1990 A
5003990 Osypka Apr 1991 A
5057114 Wittich et al. Oct 1991 A
5129749 Sato Jul 1992 A
5171233 Amplatz et al. Dec 1992 A
5193540 Schulman et al. Mar 1993 A
5257634 Kroll Nov 1993 A
5282845 Bush et al. Feb 1994 A
5300107 Stokes et al. Apr 1994 A
5318528 Heaven et al. Jun 1994 A
5336253 Gordon et al. Aug 1994 A
5405367 Schulman et al. Apr 1995 A
5405374 Stein Apr 1995 A
5411535 Fujii et al. May 1995 A
5425756 Heil et al. Jun 1995 A
5443492 Stokes et al. Aug 1995 A
5492119 Abrams Feb 1996 A
5522875 Gates et al. Jun 1996 A
5522876 Rusink Jun 1996 A
5545201 Helland et al. Aug 1996 A
5545206 Carson Aug 1996 A
5562723 Rugland et al. Oct 1996 A
5575814 Giele et al. Nov 1996 A
5578068 Laske et al. Nov 1996 A
5697936 Shipko et al. Dec 1997 A
5716390 Li Feb 1998 A
5716391 Grandjean Feb 1998 A
5755764 Schroeppel May 1998 A
5776178 Pohndorf et al. Jul 1998 A
5807399 Laske et al. Sep 1998 A
5837006 Ocel et al. Nov 1998 A
5837007 Altman et al. Nov 1998 A
5851226 Skubitz et al. Dec 1998 A
5871531 Struble Feb 1999 A
5908381 Aznoian et al. Jun 1999 A
5908447 Schroeppel et al. Jun 1999 A
6041258 Cigaina et al. Mar 2000 A
6055457 Bonner Apr 2000 A
6074401 Gardnier et al. Jun 2000 A
6078840 Stokes Jun 2000 A
6093177 Javier et al. Jul 2000 A
6129749 Bartig et al. Oct 2000 A
6132456 Sommer et al. Oct 2000 A
6181973 Ceron et al. Jan 2001 B1
6188932 Lindegren Feb 2001 B1
6240322 Peterfeso et al. May 2001 B1
6251104 Kesten et al. Jun 2001 B1
6290719 Garberoglio Sep 2001 B1
6321124 Cigaina Nov 2001 B1
6322548 Payne et al. Nov 2001 B1
RE37463 Altman Dec 2001 E
6358256 Reinhardt Mar 2002 B1
6363938 Saadat et al. Apr 2002 B2
6381495 Jenkins Apr 2002 B1
6381500 Fischer, Sr. Apr 2002 B1
6408214 Williams et al. Jun 2002 B1
6458145 Ravenscroft et al. Oct 2002 B1
6477423 Jenkins Nov 2002 B1
6500182 Foster Dec 2002 B2
6510332 Greenstein Jan 2003 B1
6510345 Van Bentem Jan 2003 B1
6522915 Ceballos et al. Feb 2003 B1
6572587 Lerman et al. Jun 2003 B2
6582441 He et al. Jun 2003 B1
6592581 Bowe Jul 2003 B2
6623518 Thompson et al. Sep 2003 B2
6626915 Leveillee Sep 2003 B2
6638268 Niazi Oct 2003 B2
6684109 Osypka Jan 2004 B1
6711443 Osypka Mar 2004 B2
6738672 Schulman et al. May 2004 B2
6743240 Smith et al. Jun 2004 B2
6755812 Peterson et al. Jun 2004 B2
6823217 Rutten et al. Nov 2004 B2
6909920 Lokhoff et al. Jun 2005 B2
6944507 Froberg Sep 2005 B2
6953454 Peterson et al. Oct 2005 B2
7027876 Casavant et al. Apr 2006 B2
7082335 Klein et al. Jul 2006 B2
7082336 Ransbury et al. Jul 2006 B2
7085606 Flach et al. Aug 2006 B2
7092765 Geske et al. Aug 2006 B2
7092766 Salys et al. Aug 2006 B1
7120504 Osypka Oct 2006 B2
7130700 Gardeski et al. Oct 2006 B2
7149587 Wardle et al. Dec 2006 B2
7158838 Seifert et al. Jan 2007 B2
7162310 Doan Jan 2007 B2
7181288 Rezai et al. Feb 2007 B1
7187982 Seifert et al. Mar 2007 B2
7200437 Nabutovsky et al. Apr 2007 B1
7212869 Wahlstrom et al. May 2007 B2
7229415 Schwartz Jun 2007 B2
7251532 Hess et al. Jul 2007 B2
7289853 Campbell et al. Oct 2007 B1
7313445 McVenes et al. Dec 2007 B2
7326231 Phillips et al. Feb 2008 B2
7328071 Stehr et al. Feb 2008 B1
7331922 Mohl Feb 2008 B2
7383091 Chitre et al. Jun 2008 B1
7450999 Karicherla et al. Nov 2008 B1
7462184 Worley et al. Dec 2008 B2
7463933 Wahlstrom et al. Dec 2008 B2
7499758 Cates et al. Mar 2009 B2
7509169 Eigler et al. Mar 2009 B2
7515971 Doan Apr 2009 B1
7532939 Sommer et al. May 2009 B2
7558631 Cowan et al. Jul 2009 B2
7634319 Schneider et al. Dec 2009 B2
7647109 Hastings et al. Jan 2010 B2
7657325 Williams Feb 2010 B2
7678128 Boyle et al. Mar 2010 B2
7717899 Bowe et al. May 2010 B2
7731655 Smith et al. Jun 2010 B2
7734343 Ransbury et al. Jun 2010 B2
7740640 Ginn Jun 2010 B2
7785264 Hettrick et al. Aug 2010 B2
7799037 He et al. Sep 2010 B1
7801624 Flannery et al. Sep 2010 B1
7835801 Sundararajan et al. Nov 2010 B1
7840281 Kveen et al. Nov 2010 B2
7840283 Bush et al. Nov 2010 B1
7860580 Falk et al. Dec 2010 B2
7875049 Eversull et al. Jan 2011 B2
7890186 Wardle et al. Feb 2011 B2
7904179 Rutten et al. Mar 2011 B2
7920928 Yang et al. Apr 2011 B1
7949395 Kuzma May 2011 B2
7993351 Worley et al. Aug 2011 B2
8010209 Jacobson Aug 2011 B2
8012127 Lieberman et al. Sep 2011 B2
8032219 Neumann et al. Oct 2011 B2
8036757 Worley Oct 2011 B2
8057486 Hansen Nov 2011 B2
8082035 Glukhovsky Dec 2011 B2
8103361 Moser Jan 2012 B2
8108054 Helland Jan 2012 B2
8142347 Griego et al. Mar 2012 B2
8160722 Rutten et al. Apr 2012 B2
8170690 Morgan et al. May 2012 B2
8185213 Kveen et al. May 2012 B2
8219213 Sommer et al. Jul 2012 B2
8233994 Sommer et al. Jul 2012 B2
8252019 Fleming, III Aug 2012 B2
8262672 Neidert et al. Sep 2012 B2
8295939 Jacobson Oct 2012 B2
8313445 Mishima et al. Nov 2012 B2
8352025 Jacobson Jan 2013 B2
8352028 Wenger Jan 2013 B2
8364277 Glukhovsky Jan 2013 B2
8364280 Marnfeldt et al. Jan 2013 B2
8406900 Barlov et al. Mar 2013 B2
8406901 Starkebaum et al. Mar 2013 B2
8418362 Zerfas et al. Apr 2013 B2
8428750 Kolberg Apr 2013 B2
8452420 Flach et al. May 2013 B2
8478431 Griswold et al. Jul 2013 B2
8489189 Tronnes Jul 2013 B2
8494650 Glukhovsky et al. Jul 2013 B2
8504156 Bonner et al. Aug 2013 B2
8518060 Jelich et al. Aug 2013 B2
8527068 Ostroff Sep 2013 B2
8532790 Griswold Sep 2013 B2
8548605 Ollivier Oct 2013 B2
8565897 Regnier et al. Oct 2013 B2
8615310 Khairkhahan et al. Dec 2013 B2
8634912 Bornzin et al. Jan 2014 B2
8670842 Bornzin et al. Mar 2014 B1
8700181 Bornzin et al. Apr 2014 B2
8721587 Berthiaume et al. May 2014 B2
8727996 Allan et al. May 2014 B2
8738147 Hastings et al. May 2014 B2
8755909 Sommer et al. Jun 2014 B2
8758365 Bonner et al. Jun 2014 B2
9119959 Rys et al. Sep 2015 B2
9155882 Grubac et al. Oct 2015 B2
9414857 Wood et al. Aug 2016 B2
9446248 Sheldon et al. Sep 2016 B2
9526891 Eggen et al. Dec 2016 B2
9539423 Bonner et al. Jan 2017 B2
10071243 Kuhn et al. Sep 2018 B2
10099050 Chen et al. Oct 2018 B2
20020077556 Schwartz Jun 2002 A1
20020095203 Thompson et al. Jul 2002 A1
20030004537 Boyle et al. Jan 2003 A1
20030233139 Chitre Dec 2003 A1
20040147973 Hauser Jul 2004 A1
20040176797 Opolski Sep 2004 A1
20040230280 Cates Nov 2004 A1
20040249417 Ransbury et al. Dec 2004 A1
20050090890 Wu et al. Apr 2005 A1
20050267555 Marnfeldt et al. Dec 2005 A1
20060085039 Hastings et al. Apr 2006 A1
20060247753 Wenger et al. Nov 2006 A1
20070043414 Fifer Feb 2007 A1
20070135883 Drasler et al. Jun 2007 A1
20070150037 Hastings et al. Jun 2007 A1
20070150038 Hastings et al. Jun 2007 A1
20070233218 Kolberg Oct 2007 A1
20070239248 Hastings et al. Oct 2007 A1
20070255376 Michels et al. Nov 2007 A1
20070276444 Gelbart Nov 2007 A1
20070293904 Gelbart Dec 2007 A1
20080021532 Kveen et al. Jan 2008 A1
20080051863 Schneider Feb 2008 A1
20090082827 Kveen et al. Mar 2009 A1
20090082828 Ostroff Mar 2009 A1
20090204170 Hastings et al. Aug 2009 A1
20090281605 Marnfeldt et al. Nov 2009 A1
20100198288 Ostroff Aug 2010 A1
20100211149 Morgan et al. Aug 2010 A1
20110034939 Kveen et al. Feb 2011 A1
20110054555 Williams et al. Mar 2011 A1
20110112548 Fifer et al. May 2011 A1
20110125163 Rutten et al. May 2011 A1
20110190785 Gerber et al. Aug 2011 A1
20110190786 Gerber et al. Aug 2011 A1
20110208260 Jacobson Aug 2011 A1
20110237967 Moore et al. Sep 2011 A1
20110251660 Griswold Oct 2011 A1
20110251661 Fifer et al. Oct 2011 A1
20110251662 Griswold et al. Oct 2011 A1
20110270339 Murray, III et al. Nov 2011 A1
20110270340 Pellegini et al. Nov 2011 A1
20110282423 Jacobson Nov 2011 A1
20110307043 Ollivier Dec 2011 A1
20120078322 Dal Molin et al. Mar 2012 A1
20120078336 Helland Mar 2012 A1
20120095539 Khairkhahan et al. Apr 2012 A1
20120109002 Mothilal et al. May 2012 A1
20120109079 Asleson et al. May 2012 A1
20120109148 Bonner et al. May 2012 A1
20120109149 Bonner et al. May 2012 A1
20120116489 Khairkhahan et al. May 2012 A1
20120158111 Khairkhahan et al. Jun 2012 A1
20120165827 Khairkhahan et al. Jun 2012 A1
20120172690 Anderson et al. Jul 2012 A1
20120172891 Lee Jul 2012 A1
20120172892 Grubac et al. Jul 2012 A1
20120197373 Khairkhahan et al. Aug 2012 A1
20120232565 Kveen et al. Sep 2012 A1
20120271134 Allan et al. Oct 2012 A1
20120330392 Regnier et al. Dec 2012 A1
20130006261 Lampropoulos et al. Jan 2013 A1
20130006262 Lampropoulos et al. Jan 2013 A1
20130012925 Berthiaume et al. Jan 2013 A1
20130035636 Beasley et al. Feb 2013 A1
20130035748 Bonner et al. Feb 2013 A1
20130053921 Bonner et al. Feb 2013 A1
20130079798 Tran et al. Mar 2013 A1
20130079861 Reinert et al. Mar 2013 A1
20130103047 Steingisser et al. Apr 2013 A1
20130103049 Bonde Apr 2013 A1
20130110127 Bornzin et al. May 2013 A1
20130110219 Bornzin et al. May 2013 A1
20130116738 Samade et al. May 2013 A1
20130116740 Bornzin et al. May 2013 A1
20130116741 Bornzin et al. May 2013 A1
20130123875 Varady et al. May 2013 A1
20130131591 Berthiaume et al. May 2013 A1
20130131693 Berthiaume et al. May 2013 A1
20130253342 Griswold et al. Sep 2013 A1
20130253343 Waldhauser et al. Sep 2013 A1
20130253344 Griswold et al. Sep 2013 A1
20130253345 Griswold et al. Sep 2013 A1
20130253346 Griswold et al. Sep 2013 A1
20130253347 Griswold et al. Sep 2013 A1
20130296957 Tronnes Nov 2013 A1
20140058494 Ostroff et al. Feb 2014 A1
20140074114 Khairkhahan et al. Mar 2014 A1
20140107723 Hou et al. Apr 2014 A1
20140148815 Wenzel et al. May 2014 A1
20140180306 Grubac et al. Jun 2014 A1
20150039069 Rys et al. Feb 2015 A1
20150039070 Kuhn et al. Feb 2015 A1
20150039071 Grubac et al. Feb 2015 A1
20150051616 Haasl et al. Feb 2015 A1
20150051682 Schmidt et al. Feb 2015 A1
20150094668 Wood et al. Apr 2015 A1
20150352353 Rys et al. Dec 2015 A1
20160001068 Grubac et al. Jan 2016 A1
20160059002 Grubac et al. Mar 2016 A1
Foreign Referenced Citations (15)
Number Date Country
1003904 Jan 1977 CA
1882370 Dec 2006 CN
2053919 May 1972 DE
779080 May 2003 EP
H02-88666 Jul 1990 JP
05245215 Sep 1993 JP
2011151104 Jun 2013 RU
2010131157 Jul 1990 WO
03032807 Apr 2003 WO
2004028348 Apr 2004 WO
2009039400 Mar 2009 WO
2009042295 Apr 2009 WO
2012092067 Jul 2012 WO
2012092074 Jul 2012 WO
2014006471 Jan 2014 WO
Non-Patent Literature Citations (21)
Entry
http://www.mana-tech.com/factsheets/HomerMammalok.pdf.
Medtronic model SELECTSURE™ 3830 manual, 2013, 20 pages.
(PCT/US2017/014352) PCT Invitation to Pay Additional Fees and, Where Applicable, Protest Fee, dated Apr. 3, 2017, 7 pages.
(PCT/US2017/014361) PCT Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, dated Apr. 3, 2017, 11 pages.
(PCT/US2017/014369) PCT Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, dated May 10, 2017, 13 pages.
(PCT/US2017/014352) PCT Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration, dated May 22, 2017, 8 pages.
International Search Report from Written Opinion from International Application No. PCT/US2014/047962, dated Feb. 5, 2015, 6 pp.
International Preliminary Report on Patentability from International Application No. PCT/US2014/047962, dated Feb. 2, 2016, 7 pp.
“Homer Mammalok Gold,” accessed on or about Jan. 19, 2017, accessed from http://www.mana-tech.com/factsheets/HomerMammalok.pdf, 1 pp.
Merriam-Webster Definition of “Compound Curve,” accessed on Apr. 25, 2017, https://merriam-webster.com/dictionary/compound%20curve, 4 pp.
Spickler, et al., “Totally Self-Contained Intracardiac Pacemaker,” J. Electrocardiology, vol. 3, Nos. 3 & 4, pp. 325-331, 1970. (Applicant points out, in accordance with MPEP 609.04(a), that the year of publication, 1970 is sufficiently earlier than the effective U.S. filing date, so that the particular month of publication is not in issue.).
Prosecution History from U.S. Appl. No. 15/410,161, dated from Jan. 19, 2017 to Jun. 13, 2018, 31 pp.
Prosecution History from U.S. Appl. No. 16/158,724, dated from Oct. 12, 2018 to Nov. 29, 2018, 37 pp.
Prosecution History from U.S. Appl. No. 13/955,393, dated from Jul. 31, 2013 to Aug. 10, 2018, 71 pp.
Prosecution History from U.S. Appl. No. 16/128,270, dated from Sep. 11, 2018 to Apr. 29, 2019, 51 pp.
U.S. Appl. No. 16/128,270, filed by Jonathan L. Kuhn et al., filed on Sep. 11, 2018.
U.S. Appl. No. 16/158,724, filed by Xin Chen et al., filed on Oct. 12, 2018.
U.S. Appl. No. 15/410,161, filed by Xin Chen et al., filed on Jan. 19, 2017.
U.S. Appl. No. 13/955,393, filed by Jonathan L. Kuhn et al., filed on Jul. 31, 2013.
Response to Final Office Action dated Apr. 29, 2019, from U.S. Appl. No. 16/128,270, filed Jun. 24, 2019, 13 pp.
Notice of Allowance from U.S. Appl. No. 16/128,270, dated Aug. 21, 2019, 8 pp.
Related Publications (1)
Number Date Country
20170209688 A1 Jul 2017 US
Provisional Applications (1)
Number Date Country
62281312 Jan 2016 US